Metal Nanoparticle Agglomerates for Sustained Infection Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing infection control methods, including first aid kits and topical treatments, are inadequate for effectively preventing or managing infections from skin penetrations, burns, or oral infections, particularly against antibiotic-resistant bacteria and viruses, and there is a need for improved disinfection media that can be easily integrated into various products.
Innovation Solution
The use of metal nanoparticle agglomerates, adhered to a base substrate or dispersed in a fluid medium, which provide rapid and sustained disinfection capabilities by inactivating infective agents through multiple biocidal pathways, while minimizing toxicity and maintaining adherence to surfaces.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional disinfection agents are used in first aid kits, then they can address common infections, but they are ineffective against antibiotic-resistant bacteria and viruses
Solution Approach 1:
The patent changes the physical parameter of the disinfectant from conventional molecular size to nanoparticle scale (1-100 nm), which fundamentally alters the interaction mechanism with microorganisms. The nanoparticle size enables penetration through bacterial cell walls and viral envelopes, providing effectiveness against antibiotic-resistant strains and viruses that conventional agents cannot target
Solution Approach 2:
The patent employs composite nanoparticle formulations combining metal cores (silver, copper, zinc, or aluminum) with functional coatings or conjugates (antibodies, peptides, or other biologically active molecules). This composite structure provides both the biocidal activity of the metal core and the specific targeting capabilities of the coating, achieving broad-spectrum effectiveness against resistant pathogens
2Reliability
If aggressive disinfection treatment is applied to prevent infection, then infection risk is reduced, but toxicity to host tissues increases
Solution Approach 1:
The patent applies disinfection activity locally at the site of injury or infection rather than systemically throughout the body. The nanoparticle formulation is applied topically to the affected area, providing high concentration where needed while minimizing exposure to healthy tissues. This localized application maintains effectiveness against pathogens while reducing overall toxicity to host tissues
Solution Approach 2:
The patent modifies the chemical parameters of traditional metal disinfectants by reducing them to nanoparticle scale and controlling their surface properties through coatings. This transformation reduces the systemic toxicity associated with conventional metal-based disinfectants while maintaining or enhancing their local biocidal activity, as the nanoparticles can be precisely controlled in terms of size, surface charge, and reactivity
3Reliability
If metal nanoparticles are used for disinfection, then biocidal activity is enhanced, but stability and adherence to surfaces become challenging
Solution Approach 1:
The patent introduces intermediary substances such as surfactants, polymers, or biomolecules that coat the nanoparticle surface and mediate their interaction with surfaces. These intermediaries prevent nanoparticle aggregation by providing steric or electrostatic repulsion, while simultaneously enhancing adherence to biological surfaces through specific interactions. This mediator layer maintains nanoparticle stability in suspension and facilitates controlled deposition on target surfaces
Solution Approach 2:
The patent creates composite nanoparticle structures where a metal core is combined with a stabilizing shell or coating material. This composite structure provides both the biocidal function of the metal core and the stability/adherence properties of the coating material. The composite design allows independent optimization of biocidal activity and surface interaction properties
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Metal nanoparticle agglomerates offer robust infection control by inactivating a range of microorganisms, including antibiotic-resistant strains, with a time-release profile that sustains biocidal activity for extended periods, suitable for use in first aid kits and various medical applications.
Implementation Method 1
metal nanoparticle agglomerates... provide rapid and sustained disinfection capabilities by inactivating infective agents through multiple biocidal pathways
Implementation Method 2
metal nanoparticle agglomerates, adhered to a base substrate... maintaining adherence to surfaces
Implementation Method 3
a time-release profile that sustains biocidal activity for extended periods
Data Source
AI summary
Metal nanoparticle agglomerates in various forms may be utilized to promote infection control. Antiseptic substrates may comprise a base substrate and metal nanoparticle agglomerates adhered thereto. Metal nanoparticle agglomerates upon the antiseptic substrates may be contacted with a skin penetration, a skin injury, a burn, a site to be subjected to a skin penetration, or an active skin infection to provide infection control against at least one infective agent. The antiseptic substrates may also facilitate water purification in some cases. Antiseptic fluid formulations comprising a fluid medium having metal nanoparticle agglomerates dispersed therein may be configured for topical or oral use and may similarly afford infection control. Creams, ointments, balms, salves, gels, and liquids or liquid suspensions containing metal nanoparticle agglomerates may be effective for promoting infection control and/or for treating an active infection.